The alternative translated MDMXp60 isoform regulates MDM2 activity

Cell Cycle

Volumn 14, Issue 3, 2015, Pages 449-458

  Tournillon, Anne Sophie ^a   López, Ignacio ^a   Malbert Colas, Laurence ^a   Naski, Nadia ^a   Olivares Illana, Vanesa ^b   Fåhraeus, Robin ^a,c  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b UNIVERSIDAD AUTÓNOMA DE SAN LUIS POTOSÍ   (Mexico)

^c MASARYK MEMORIAL CANCER INSTITUTE   (Czech Republic)

Author keywords

Alternative translation; Isoforms; MDM2; MDMX; Protein stability

Indexed keywords

CELL DNA; COMPLEMENTARY DNA; MESSENGER RNA; POLYCLONAL ANTIBODY; PROTEIN MDM2; PROTEIN MDMX; PROTEIN P53; PROTEIN P60; UBIQUITIN PROTEIN LIGASE E3; CAPPED RNA; CODON; ISOPROTEIN; MDM2 PROTEIN, HUMAN; MDM4 PROTEIN, HUMAN; NUCLEAR PROTEIN; ONCOPROTEIN; PROTEIN BINDING;

5' UNTRANSLATED REGION; ARTICLE; CELL LYSATE; CODON; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; IN VITRO STUDY; OPEN READING FRAME; OSCILLATION; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN STABILITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RING FINGER MOTIF; TRANSLATION INITIATION; UBIQUITINATION; ULTRAVIOLET IRRADIATION; WESTERN BLOTTING; ALTERNATIVE RNA SPLICING; CELL LINE; GENETICS; METABOLISM; PROTEIN SYNTHESIS;

ALTERNATIVE SPLICING; CELL LINE; CODON; HUMANS; NUCLEAR PROTEINS; PROTEIN BINDING; PROTEIN BIOSYNTHESIS; PROTEIN ISOFORMS; PROTEIN STABILITY; PROTEOLYSIS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-MDM2; RNA CAPS; RNA, MESSENGER;

EID: 84923163425     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/15384101.2014.977081     Document Type: Article

References (36)

1. BlandinoG, DobbelsteinM. p73 and p63: Why do we still need them? Cell Cycle 2004; 3: 886-94; PMID: 15254416; http://dx.doi.org/10.4161/cc.3.7.996
2. Levrero M, De Laurenzi V, Costanzo A, Gong J, Wang JY, Melino G. The p53/p63/p73 family of transcription factors: Overlapping and distinct functions. J Cell Sci 2000; 113 (Pt 10): 1661-70; PMID: 10769197
3. Dotsch V, Bernassola F, Coutandin D, Candi E, Melino G. p63 and p73, the ancestors of p53. Cold Spring Harbor Perspec Biol 2010; 2: A004887; PMID: 20484388; http://dx.doi.org/10.1101/cshperspect.a004887
4. Truong AB, Khavari PA. Control of keratinocyte proliferation and differentiation by p63. Cell Cycle 2007; 6: 295-9; PMID: 17264679; http://dx.doi.org/10.4161/cc.6.3.3753
5. Murray-Zmijewski F, Lane DP, Bourdon JC. p53/p63/p73 isoforms: An orchestra of isoforms to harmonise cell differentiation and response to stress. Cell Death Differ 2006; 13: 962-72; PMID: 16601753; http://dx.doi.org/10.1038/sj.cdd.4401914
6. Moll UM, Slade N. p63 and p73: Roles in development and tumor formation. Mol Cancer Res 2004; 2: 371-86; PMID: 15280445
7. Bourougaa K, Naski N, Boularan C, Mlynarczyk C, Candeias MM, Marullo S, Fahraeus R. Endoplasmic reticulum stress induces G2 cell-cycle arrest via mRNA translation of the p53 isoform p53/47. Mol Cell 2010; 38: 78-88; PMID: 20385091; http://dx.doi.org/10.1016/j.molcel.2010.01.041
8. Fujita K, Mondal AM, Horikawa I, Nguyen GH, Kumamoto K, Sohn JJ, Bowman ED, Mathe EA, Schetter AJ, Pine SR, et al. p53 isoforms Delta133p53 and p53beta are endogenous regulators of replicative cellular senescence. Nat Cell Biol 2009; 11: 1135-42; PMID: 19701195; http://dx.doi.org/10.1038/ncb1928
9. Candeias MM, Malbert-Colas L, Powell DJ, Daskalogianni C, MaslonMM, Naski N, Bourougaa K, Calvo F, Fahraeus R. P53 mRNA controls p53 activity by managing Mdm2 functions. Nat Cell Biol 2008; 10: 1098-105; PMID: 19160491; http://dx.doi.org/10.1038/ncb1770
10. Kubbutat MH, Jones SN, Vousden KH. Regulation of p53 stability by Mdm2. Nature 1997; 387: 299-303; PMID: 9153396; http://dx.doi.org/10.1038/387299a0
11. Marine JC, Francoz S, Maetens M, Wahl G, Toledo F, Lozano G. Keeping p53 in check: Essential and synergistic functions of Mdm2 and Mdm4. Cell Death Differ 2006; 13: 927-34; PMID: 16543935; http://dx.doi.org/10.1038/sj.cdd.4401912
12. Honda R, Tanaka H, Yasuda H. Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53. FEBS Lett 1997; 420: 25-7; PMID: 9450543; http://dx.doi.org/10.1016/S0014-5793(97)01480-4
13. Maslon MM, Hupp TR. Drug discovery and mutant p53. Trends Cell Biol 2010; 20: 542-55; PMID: 20656489; http://dx.doi.org/10.1016/j.tcb.2010.06.005
14. Ganguli G, Wasylyk B. p53-independent functions of MDM2. Mol Cancer Res : MCR 2003; 1: 1027-35; PMID: 14707286
15. Manfredi JJ. The Mdm2-p53 relationship evolves: Mdm2 swings both ways as an oncogene and a tumor suppressor. Genes Dev 2010; 24: 1580-9; PMID: 20679392; http://dx.doi.org/10.1101/gad.1941710
16. Fahraeus R, Olivares-Illana V. MDM2s social network. Oncogene 2014; 33, 4365-4376; http://dx.doi.org/10.1038/onc.2013.410
17. Giglio S, Mancini F, Pellegrino M, Di Conza G, Puxeddu E, Sacchi A, Pontecorvi A, Moretti F. Regulation of MDM4 (MDMX) function by p76(MDM2): A new facet in the control of p53 activity. Oncogene 2010; 29: 5935-45; PMID: 20697359; http://dx.doi.org/10.1038/onc.2010.324
18. Bartel F, Taubert H, Harris LC. Alternative and aberrant splicing of MDM2 mRNA in human cancer. Cancer Cell 2002; 2: 9-15; PMID: 12150820; http://dx.doi.org/10.1016/S1535-6108(02)00091-0
19. Chandler DS, Singh RK, Caldwell LC, Bitler JL, Lozano G. Genotoxic stress induces coordinately regulated alternative splicing of the p53 modulators MDM2 and MDM4. Cancer Res 2006; 66: 9502-8; PMID: 17018606; http://dx.doi.org/10.1158/0008-5472.CAN-05-4271
20. Saucedo LJ, Myers CD, Perry ME. Multiple murine double minute gene 2 (MDM2) proteins are induced by ultraviolet light. J Biol Chem 1999; 274: 8161-8; PMID: 10075719; http://dx.doi.org/10.1074/jbc.274.12.8161
21. Candeias MM, Malbert-Colas L, Powell DJ, Daskalogianni C, Maslon MM, Naski N, Bourougaa K, Calvo F, Fahraeus R. p53 mRNA controls p53 activity by managing Mdm2 functions. Nat Cell Biol 2008; 10(9): 1098-105; PMID: 19160491; http://dx.doi.org/10.1038/ncb1770
22. Marine JC, Jochemsen AG. Mdmx and Mdm2: Brothers in arms? Cell Cycle 2004; 3: 900-4; PMID: 15254433; http://dx.doi.org/10.4161/cc.3.7.998
23. Danovi D, Meulmeester E, Pasini D, Migliorini D, Capra M, Frenk R, de Graaf P, Francoz S, Gasparini P, Gobbi A, et al. Amplification of Mdmx (or Mdm4) directly contributes to tumor formation by inhibiting p53 tumor suppressor activity. Mol Cell Biol 2004; 24: 5835-43; PMID: 15199139; http://dx.doi.org/10.1128/MCB.24.13.5835-5843.2004
24. Gembarska A, Luciani F, Fedele C, Russell EA, Dewaele M, Villar S, Zwolinska A, Haupt S, de Lange J, Yip D, et al. MDM4 is a key therapeutic target in cutaneous melanoma. Nat Med 2012; 18: 1239-47; PMID: 22820643; http://dx.doi.org/10.1038/nm.2863
25. Pei D, Zhang Y, Zheng J. Regulation of p53: A collaboration between Mdm2 and Mdmx. Oncotarget 2012; 3: 228-35; PMID: 22410433
26. Wang X. p53 regulation: Teamwork between RING domains of Mdm2 and MdmX. Cell Cycle 2011; 10: 4225-9; PMID: 22134240; http://dx.doi.org/10.4161/cc.10.24.18662
27. Rallapalli R, Strachan G, Cho B, Mercer WE, Hall DJ. A novel MDMX transcript expressed in a variety of transformed cell lines encodes a truncated protein with potent p53 repressive activity. J Biol Chem 1999; 274: 8299-308; PMID: 10075736; http://dx.doi.org/10.1074/jbc.274.12.8299
28. Gentiletti F, Mancini F, D'Angelo M, Sacchi A, Pontecorvi A, Jochemsen AG, Moretti F. MDMX stability is regulated by p53-induced caspase cleavage in NIH3T3 mouse fibroblasts. Oncogene 2002; 21: 867-77; PMID: 11840332; http://dx.doi.org/10.1038/sj.onc.1205137
29. Mathews M, Sonenberg N, Hershey J. Translational Control in Biology and Medicine, Mathews M. B., Sonenberg N., Hershey J. W. B., eds. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press; 2007.
30. Metzger MB, Pruneda JN, Klevit RE, Weissman AM. RING-type E3 ligases: Master manipulators of E2 ubiquitin-conjugating enzymes and ubiquitination. Biochimica et Biophy Acta 2014; 1843: 47-60; PMID: 23747565; http://dx.doi.org/10.1016/j.bbamcr.2013.05.026
31. Rocco JW, Ellisen LW. p63 and p73: Life and death in squamous cell carcinoma. Cell Cycle 2006; 5: 936-40; PMID: 16687923; http://dx.doi.org/10.4161/cc.5.9.2716
32. Sharp DA, Kratowicz SA, Sank MJ, George DL. Stabilization of the MDM2 oncoprotein by interaction with the structurally related MDMX protein. J Biol Chem 1999; 274: 38189-96; PMID: 10608892; http://dx.doi.org/10.1074/jbc.274.53.38189
33. Stad R, Ramos YF, Little N, Grivell S, Attema J, van Der Eb AJ, Jochemsen AG. Hdmx stabilizes Mdm2 and p53. J Biol Chem 2000; 275: 28039-44; PMID: 10827196
34. Linares LK, Hengstermann A, Ciechanover A, Muller S, Scheffner M. HdmX stimulates Hdm2-mediated ubiquitination and degradation of p53. Proc Natl Acad Sci U S A 2003; 100: 12009-14; PMID: 14507994; http://dx.doi.org/10.1073/pnas.2030930100
35. Wallace M, Worrall E, Pettersson S, Hupp TR, Ball KL. Dual-site regulation of MDM2 E3-ubiquitin ligase activity. Mol Cell 2006; 23: 251-63; PMID: 16857591; http://dx.doi.org/10.1016/j.molcel.2006.05.029
36. Kulikov R, Letienne J, Kaur M, Grossman SR, Arts J, Blattner C. Mdm2 facilitates the association of p53 with the proteasome. Proc Natl Acad Sci U S A 2010; 107: 10038-43; PMID: 20479273; http://dx.doi.org/10.1073/pnas.0911716107